콘텐츠로 건너뛰기
주식/증권 ➡️ 중립

Is This the Right Time to Hold CRL Stock in Your Portfolio?

요약

Charles River leans on RMS strength, CRADL adoption and portfolio moves. Can these offset soft biopharma demand and currency headwinds?